SCID mice challenged with the CD19+ CD38+ human Burkitt’s lymphoma cell line Ramos treated with three daily injections of anti-CD19 BU12-SAP IT or of anti-CD38 OKT10-SAP IT starting at day +7 showed significantly prolonged survival. The gene discussed is CD38; the disease is Burkitt lymphoma.